Skip to Main Content

Paper Details

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.
Science
904
2020
Ebola, SARS, SARS-CoV-2, SARS-CoV-2 antibody, human, humanized, humanized mice, humans, infectious diseases, mice, patients, receptor binding domain, severe acute respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus 2
Author NameAffiliation
Pascal BouffardRegeneron Pharmaceuticals, Inc.
Stuart WestonUniversity of Maryland School of Medicine
James LogueUniversity of Maryland School of Medicine
Matthew B FriemanUniversity of Maryland School of Medicine
Matthew B FriemanUniversity of Maryland School of Medicine
Andrew J MurphyRegeneron Pharmaceuticals, Inc.
George D YancopoulosRegeneron Pharmaceuticals, Inc.
  • 1 - 7

Datasets

Release 1.2